Statin effects on regulatory and proinflammatory factors in chronic idiopathic urticaria
- 作者M. H. Azor; J. C. dos Santos; E. A. Futata; C. A. de Brito; C. W. Maruta; E. A. Rivitti; A. J. da Silva Duarte; M. N. Sato
- 卷第166卷
- 期第2期
- 印刷ISSN0009-9104
- 电子ISSN1365-2249
- 文件大小618.45KB
- 发表时间2011
- DOI10.1111/j.1365-2249.2011.04473.x
- 页码291-298
Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in CanadaGerth, William C; Betschel, Stephen D; Zbrozek, Arthur S · Allergy, Asthma & Clinical Immunology · 2014
Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)Gill, Parwinder K.; Betschel, Stephen D. · Allergy, Asthma & Clinical Immunology · 2018
Intravenous immunoglobulins in the therapy of severe bacterial infections, immunodeficiencies, and autoimmune diseasesM Popovic; B Glisic; D Mitrovic; D Stefanovic; M Dimitrijevic · 2001
Economic Evaluation of 10% Intravenous Immunoglobulin In Treatment of Primary Immunodeficiencies In Adults In The Russian FederationUgrekhelidze, D; Yagudina, R; Kulikov, A · Value in Health · 2017
Prophylactic and therapeutic use of immunoglobulin for intravenous administration in patients with secondary immunodeficiencies associated with malignanciesMORELL, ANDREAS; BARANDUN, SILVIO · The Pediatric Infectious Disease Journal · 1988
Cost-Minimization Analysis of 10% Intravenous Immunoglobulin In Treatment Of Primary Immunodeficiencies In Children In The Russian FederationUgrekhelidze, D; Yagudina, R; Kulikov, A · Value in Health · 2017
Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in CanadaGerth, William C; Betschel, Stephen D; Zbrozek, Arthur S · Allergy, Asthma & Clinical Immunology · 2014